These benefits enable a prime editor to create NAFLD polymorphisms that base editors cannot generate, such as PNPLA3 rs738409 (C > G) and HMOX1 rs2071746 (A > T). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.